1 - 25 of 47 results for author:"Superti-Furga G." in Literature citations
Results Customize
› Repeat search in UniProtKB (5,050)
| Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins. Abbas Y.M., Pichlmair A., Gorna M.W., Superti-Furga G., Nagar B. Nature 494:60-64(2013) · UniProtKB (2) |
| Mig6 is a sensor of EGF receptor inactivation that directly activates c-Abl to induce apoptosis during epithelial homeostasis. Hopkins S., Linderoth E., Hantschel O., Suarez-Henriques P., Pilia G., Kendrick H., Smalley M.J., Superti-Furga G., Ferby I. Dev. Cell 23:547-559(2012) · Mapped (10) |
| Viral immune modulators perturb the human molecular network by common and unique strategies. Pichlmair A., Kandasamy K., Alvisi G., Mulhern O., Sacco R., Habjan M., Binder M., Stefanovic A., Eberle C.A., Goncalves A. et al. Nature 487:486-490(2012) · Mapped (14) |
| SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutieres syndrome-associated mutations. Goncalves A., Karayel E., Rice G.I., Bennett K.L., Crow Y.J., Superti-Furga G., Burckstummer T. Hum. Mutat. 33:1116-1122(2012) · Mapped (3) |
| Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression. Kachaner D., Filipe J., Laplantine E., Bauch A., Bennett K.L., Superti-Furga G., Israel A., Weil R. Mol. Cell 45:553-566(2012) · Mapped (3) |
| BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. Hantschel O., Warsch W., Eckelhart E., Kaupe I., Grebien F., Wagner K.U., Superti-Furga G., Sexl V. Nat. Chem. Biol. 8:285-293(2012) · Mapped (9) |
| Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis. Grebien F., Hantschel O., Wojcik J., Kaupe I., Kovacic B., Wyrzucki A.M., Gish G.D., Cerny-Reiterer S., Koide A., Beug H. et al. Cell 147:306-319(2011) · Mapped (12) |
| Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Weismann D., Hartvigsen K., Lauer N., Bennett K.L., Scholl H.P., Charbel Issa P., Cano M., Brandstatter H., Tsimikas S., Skerka C. et al. Nature 478:76-81(2011) · Mapped (8) |
| Functional dissection of the TBK1 molecular network. Goncalves A., Burckstummer T., Dixit E., Scheicher R., Gorna M.W., Karayel E., Sugar C., Stukalov A., Berg T., Kralovics R. et al. PLoS ONE 6:e23971-e23971(2011) · Mapped (5) |
| IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Pichlmair A., Lassnig C., Eberle C.A., Gorna M.W., Baumann C.L., Burkard T.R., Buerckstuemmer T., Stefanovic A., Krieger S., Bennett K.L. et al. |
| Initial characterization of the human central proteome. Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) · UniProtKB (5,017) |
| CD14 is a coreceptor of Toll-like receptors 7 and 9. Baumann C.L., Aspalter I.M., Sharif O., Pichlmair A., Bluml S., Grebien F., Bruckner M., Pasierbek P., Aumayr K., Planyavsky M. et al. J. Exp. Med. 207:2689-2701(2010) · Mapped (11) |
| Peroxisomes are signaling platforms for antiviral innate immunity. Dixit E., Boulant S., Zhang Y., Lee A.S., Odendall C., Shum B., Hacohen N., Chen Z.J., Whelan S.P., Fransen M. et al. |
| A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Wojcik J., Hantschel O., Grebien F., Kaupe I., Bennett K.L., Barkinge J., Jones R.B., Koide A., Superti-Furga G., Koide S. Nat. Struct. Mol. Biol. 17:519-527(2010) · UniProtKB (1) |
| The TLR-independent DNA recognition pathway in murine macrophages: Ligand features and molecular signature. Karayel E., Burckstummer T., Bilban M., Durnberger G., Weitzer S., Martinez J., Superti-Furga G. Eur. J. Immunol. 39:1929-1936(2009) · Mapped (3) |
| The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia. Hantschel O., Gstoettenbauer A., Colinge J., Kaupe I., Bilban M., Burkard T.R., Valent P., Superti-Furga G. Mol Oncol 2:272-281(2008) · Mapped (14) |
| The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2). Winger J.A., Hantschel O., Superti-Furga G., Kuriyan J. BMC Struct. Biol. 9:7-7(2009) · UniProtKB (1) |
| An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Burckstummer T., Baumann C., Bluml S., Dixit E., Durnberger G., Jahn H., Planyavsky M., Bilban M., Colinge J., Bennett K.L. et al. Nat. Immunol. 10:266-272(2009) · UniProtKB (1) · Mapped (62) |
| Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases. De Keersmaecker K., Versele M., Cools J., Superti-Furga G., Hantschel O. Leukemia 22:2208-2216(2008) · Mapped (46) |
| Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Filippakopoulos P., Kofler M., Hantschel O., Gish G.D., Grebien F., Salah E., Neudecker P., Kay L.E., Turk B.E., Superti-Furga G. et al. |
| The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. Soulat D., Burckstummer T., Westermayer S., Goncalves A., Bauch A., Stefanovic A., Hantschel O., Bennett K.L., Decker T., Superti-Furga G. |
| Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia. Sherbenou D.W., Hantschel O., Turaga L., Kaupe I., Willis S., Bumm T., Press R.D., Superti-Furga G., Druker B.J., Deininger M.W. Leukemia 22:1184-1190(2008) · Mapped (28) |
| The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Kneidinger M., Schmidt U., Rix U., Gleixner K.V., Vales A., Baumgartner C., Lupinek C., Weghofer M., Bennett K.L., Herrmann H. et al. Blood 111:3097-3107(2008) · Mapped (3) |
| The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Hantschel O., Rix U., Schmidt U., Burckstummer T., Kneidinger M., Schutze G., Colinge J., Bennett K.L., Ellmeier W., Valent P. et al. Proc. Natl. Acad. Sci. U.S.A. 104:13283-13288(2007) · Mapped (3) |
| Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling. Angrand P.O., Segura I., Volkel P., Ghidelli S., Terry R., Brajenovic M., Vintersten K., Klein R., Superti-Furga G., Drewes G. et al. Mol. Cell Proteomics 5:2211-2227(2006) · Mapped (38) |